Clinical Research and Regulatory Affairs

Publisher： Informa Healthcare

Founded in： 1983

Total resources： 4

E-ISSN： 1532-2521

ISSN： 1060-1333

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Research and Regulatory Affairs

Menu

The pharmacodynamic equivalence of Orlistat 60 mg capsule. An open label, balanced, randomized, multiple-dose, cross-over pharmacodynamic end-point bioequivalence study in healthy, adult, human Asian Indian subjects under fed conditions

By Kumar Sudershan,Monif Tausif,Arora Rachna,Khuroo Arshad,Jain Rakesh,Reyar Simrit,Verma Priya Ranjan Prasad,Rao Shireen in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 4, 2013-12 , pp. 55-62

Informa Healthcare

Abstract Access to resources Recommend Favorite

Reducing the average number of patients needed in a phase II trial through novel design

By Wason James M. S. in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 4, 2013-12 , pp. 47-54

Informa Healthcare

Abstract Access to resources Recommend Favorite

Steady state bioequivalence study of dipyridamole ER and acetyl salicylic acid 200 mg + 25 mg capsules in adult healthy male and female volunteers under fasting condition

By Tippabhotla Sudhakar Koundinya,Yergude Sandeep,Gadiko Chaitanya,Thota Satyanarayana,Khan Sohel Md.,Battula Ramakrishna,Vobalaboina Venkateswarlu in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 3, 2013-09 , pp. 38-45

Informa Healthcare

Abstract Access to resources Recommend Favorite

Statement of Retraction

By in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 3, 2013-09 , pp. 46-46

Informa Healthcare

Abstract Access to resources Recommend Favorite

Blinded independent central reviews: The FDA weighs in

By Walovitch Richard C. in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 3, 2013-09 , pp. 33-37

Informa Healthcare

Abstract Access to resources Recommend Favorite

Single dose pharmacokinetics and bioequivalence of conjugated estrogens (0.625 mg × 2) tablets in healthy post-menopausal female subjects in fasting and fed studies

By Tippabhotla Sudhakar Koundinya,Nakkawar Mukesh,Gadiko Chaitanya,Betha Madhava Rao,Khan Sohel Md.,Yergude Sandeep,Thota Satyanarayana,Cheerla Raju,Battula Ramakrishna,Vobalaboina Venkateswarlu in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 1-2, 2013-03 , pp. 23-30

Informa Healthcare

Abstract Access to resources Recommend Favorite

Clinical Research and Regulatory Affairs invites you to submit your research

By Hunter Dawn in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 1-2, 2013-03 , pp. 31-31

Informa Healthcare

Abstract Access to resources Recommend Favorite

Advance Oracle Clinical Software tool used in clinical research from patient data collection to data base lock

By Kunithala Vasanth Kumar,Kabeer Ahamed,Vemula Sateesh Kumar in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 1-2, 2013-03 , pp. 1-13

Informa Healthcare

Abstract Access to resources Recommend Favorite

Pharmacokinetics of two formulations of alendronate sodium/cholecalciferol (vitamin D3) tablets 70 mg/5600 IU: An open-label, randomized, single-dose, two-treatment, two-period, two-sequence, cross-over, bioequivalence study

By Tippabhotla Sudhakar Koundinya,Thota Satyanarayana,Khan Sohel Md.,Gadiko Chaitanya,Yergude Sandeep,Cheerla Raju,Nakkawar Mukesh,Betha Madhava Rao,Battula Ramakrishna,Vobalaboina Venkateswarlu in (2013)

Clinical Research and Regulatory Affairs , Vol. 30, Iss. 1-2, 2013-03 , pp. 14-22

Informa Healthcare

Abstract Access to resources Recommend Favorite

Retracted: Prescription to over-the-counter movement and its regulations

By Dubey S. K. in (2012)

Clinical Research and Regulatory Affairs , Vol. 29, Iss. 3-4, 2012-12 , pp. 57-64

Informa Healthcare

Abstract Access to resources Recommend Favorite

Total 10 item(s)